OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 01, 2006
Latin America has become a promising region for the pharmaceutical industry in terms of both R&D and sales. Nowhere has this been more apparent than in Mexico, which has become a top priority market for many of the major multinational pharmaceutical companies. Furthermore, the Mexican government is increasing its investment in healthcare resources and there is a strong, growing demand from the population for access to newer and better medical treatments.
January 01, 2006
Is the lack of finance necessarily spelling doom for the European biotech industry?
The big question for pharmaceutical services providers coming into 2006 is: will the good times continue to roll?
December 02, 2005
CROs and CMOs are pursuing new strategies to win a larger share of the burgeoning early development pipeline.
December 01, 2005
OTC Eye-Drop Maker Signs Consent Decree
November 23, 2005
Pfizer to Shut Parsippany Plant
November 07, 2005
Contract services providers gained a valuable look into major market conditions, offshoring trends, and 2006 growth opportunities during a morning presentation entitled "CMC Sourcing in transition: Consolidation, Offshoring, and the Market Outlook," presented by Jim Miller. Miller is president of PharmSource (Springfield, VA, www.pharmsource.com), publisher of the Bio/Pharmaceutical Outsourcing , and contributing editor of Pharmaceutical Technology.
November 03, 2005
Roche Puts Hold on Tamiflu in US
Novartis Purchases Chiron in a Total Buyout
November 02, 2005
As major pharmaceutical companies take initial steps to prune their supplier base and negotiate better pricing, nonpharmaceutical companies that took those measures 10 years ago are moving to next-generation sourcing strategies. In designing those plans, these front-runners are applying two key lessons learned in recent years: supplier consolidation often doesn't go far enough, whereas price cutting can go too far.